Scott J Hollister — Dr. Scott J. Hollister's lab at Georgia Tech focuses on improving medical implants and devices for various applications, including facial reconstruction and airway support in children. The research aims to understand how skin and airway tissues respond to implants and to design new, better-performing devices using advanced techniques like 3D printing and computer modeling. By studying tissue responses and complications in animal models, the lab hopes to mitigate risks associated with these devices in clinical settings.
Stanislav Y Emelianov — Dr. Stanislav Y. Emelianov's lab at Georgia Tech focuses on enhancing cancer therapy through innovative techniques that improve the effectiveness of CAR T cell treatment for solid tumors, such as breast cancer. By using advanced imaging methods and unique gene switches that activate CAR T cells at specific temperatures, the lab aims to deliver targeted therapy while minimizing side effects. This cutting-edge research merges engineering with cancer treatment to create safer and more effective therapeutic options for patients.
Ravi S. Kane — Dr. Ravi S. Kane's lab focuses on creating innovative vaccines to tackle influenza viruses, including those responsible for historic pandemics. By engineering the protein hemagglutinin and its presentation on multivalent scaffolds, the lab aims to develop vaccines that elicit strong immune responses against the conserved parts of these viruses, which could help in managing seasonal flu and preventing future pandemics.
Marvin Whiteley — Dr. Marvin Whiteley's lab at Georgia Tech studies the bacterium Pseudomonas aeruginosa, which causes hard-to-treat infections, especially in chronic wounds. They focus on understanding how specific small RNA molecules influence the bacteria's ability to survive and thrive in human infections. By uncovering these mechanisms, the lab aims to find better diagnostics and treatments for serious infections.
Hang Lu — Dr. Hang Lu's lab studies the aging process using the model organism C. elegans, a small worm. The lab aims to understand how behavioral changes relate to neural activity over time, especially how these dynamics affect health and longevity. Through innovative technologies and computational models, the team hopes to unveil the mechanisms behind aging, which could lead to strategies for healthier aging in various species, including humans.
F. Levent Degertekin — Dr. F. Levent Degertekin's lab at Georgia Tech focuses on advancing cardiac procedures through innovative catheter technology. Their latest project aims to develop a combined intravascular ultrasound (IVUS) and fractional flow reserve (FFR) microcatheter that will improve the safety and effectiveness of percutaneous coronary interventions, a common heart procedure. By integrating imaging and pressure measurement capabilities into a single device, the lab seeks to optimize patient outcomes while reducing risks and costs associated with these complex procedures.
Susan Napier Thomas — Dr. Susan Napier Thomas's lab focuses on developing new therapies for lymphedema, a condition that causes swelling and fibrosis due to improper lymphatic drainage, often seen in breast cancer survivors. The research involves creating innovative drug delivery systems that target lymphatic tissues to improve lymphatic function and reduce inflammation. By using pre-clinical models and advanced imaging, the lab seeks to replace outdated treatment strategies with effective drug therapies.
Ankur Singh — Dr. Ankur Singh's lab at Georgia Tech focuses on improving our understanding of immune responses, particularly in B cells, which are crucial for fighting infections and diseases like lymphoma. They develop innovative hydrogel-based structures that mimic lymphoid tissues to study how human B cells can be activated and sustained over time. This research aims to address significant challenges in vaccine development and racial disparities in cancer outcomes.
Ronghu Wu — Dr. Ronghu Wu's lab at Georgia Institute of Technology focuses on understanding the roles of glycoproteins, which are proteins that have sugar molecules attached to them, in health and disease. The research is particularly relevant to conditions like cancer and infections, as these glycoproteins can serve as crucial indicators for disease diagnosis and potential drug targets. The lab develops innovative techniques to study these molecules to better understand their functions and interactions in various biological processes.